Analysts think AMRN stock price could increase by 92%
Mar 09, 2025, 11:25 AM
0.00%
What does AMRN do
Amarin Plc is a pharmaceutical company focused on developing and commercializing cardiovascular therapeutics, primarily VASCEPA, which reduces triglyceride levels in patients with severe hypertriglyceridemia. VASCEPA is marketed through wholesalers and specialty pharmacies.
3 analysts think AMRN stock price will increase by 92.27%. The current median analyst target is $1.02 compared to a current stock price of $0.53. The lowest analysts target is $1.01 and the highest analyst target is $1.05.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.